Successful treatment of metastatic malignant fibrous histiocytoma of the kidney

Urol Int. 2010;85(1):118-20. doi: 10.1159/000315874. Epub 2010 Jun 1.

Abstract

Malignant fibrous histiocytoma (MFH) of the kidney is a rare sarcoma that often undergoes local recurrence and/or distant metastasis. However, little is known about the outcome of metastatic diseases. We present the case of a 46-year-old male suffering from renal MFH with pulmonary metastasis, who has undergone complete response for 3 years after surgical resection and MAID chemotherapy. He is now well, and without any evidence of recurrent disease.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Biopsy
  • Chemotherapy, Adjuvant
  • Dacarbazine / administration & dosage
  • Doxorubicin / administration & dosage
  • Histiocytoma, Malignant Fibrous / diagnostic imaging
  • Histiocytoma, Malignant Fibrous / secondary
  • Histiocytoma, Malignant Fibrous / therapy*
  • Humans
  • Ifosfamide / administration & dosage
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / therapy*
  • Lung Neoplasms / diagnostic imaging
  • Lung Neoplasms / secondary
  • Lung Neoplasms / therapy*
  • Male
  • Mesna / administration & dosage
  • Middle Aged
  • Nephrectomy*
  • Thoracoscopy*
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Dacarbazine
  • Doxorubicin
  • Mesna
  • Ifosfamide

Supplementary concepts

  • MAID protocol